MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$170,676K
Cash and cash
equivalents
$90,853K
Trade accounts
receivable, net
$62,509K
Inventories
$48,428K
Prepaid expenses and
other current assets
$19,530K
Total current assets
$391,996K
Property and equipment,
net
$18,009K
Intangible assets, net
$16,821K
Goodwill
$16,697K
Operating lease
right-of-use assets
$11,315K
Other noncurrent
assets
$6,704K
Total assets
$461,542K
Total liabilities and
stockholders equity
$461,542K
Total stockholders
equity
$341,739K
Total liabilities
$119,803K
Accumulated deficit
-$101,738K
Additional paid-in capital
$441,107K
Total current
liabilities
$77,804K
Deferred revenue,
noncurrent
$18,339K
Operating lease
liability, noncurrent
$14,042K
Legal settlement
liability, noncurrent
$6,786K
Other noncurrent
liabilities
$2,307K
Long term debt
$525K
Accumulated other
comprehensive income
$2,241K
Common stock, 0.001 par
value 1,000,000,000...
$129K
Deferred revenue,
current
$28,504K
Accrued expenses
$23,417K
Other current
liabilities
$16,978K
Trade accounts
payable
$6,410K
Legal settlement
liability, current
$2,495K
Back
Back
Balance Sheet
source: myfinsight.com
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)